{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T01:57:13Z","timestamp":1784858233407,"version":"3.55.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001511","name":"Auckland Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001511","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.iac.2020.03.001","type":"journal-article","created":{"date-parts":[[2020,6,7]],"date-time":"2020-06-07T07:33:08Z","timestamp":1591515188000},"page":"403-420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Defining Common Variable Immunodeficiency Disorders in 2020"],"prefix":"10.1016","volume":"40","author":[{"given":"Rohan","family":"Ameratunga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Allan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"See-Tarn","family":"Woon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.iac.2020.03.001_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1999.4725","article-title":"Common variable immunodeficiency: clinical and immunological features of 248 patients","volume":"92","author":"Cunningham-Rundles","year":"1999","journal-title":"Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2020.03.001_bib2","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s10875-007-9075-1","article-title":"Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency","volume":"27","author":"Quinti","year":"2007","journal-title":"J\u00a0Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2020.03.001_bib3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.iac.2020.03.001_bib4","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.3389\/fimmu.2018.02130","article-title":"Assessing disease severity in Common Variable Immunodeficiency Disorders (CVID) and CVID-like disorders","volume":"9","author":"Ameratunga","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.iac.2020.03.001_bib5","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaci.2013.12.1077","article-title":"Clinical picture and treatment of 2212 patients with common variable immunodeficiency","volume":"134","author":"Gathmann","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.iac.2020.03.001_bib6","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1086\/587669","article-title":"Infections in 252 patients with common variable immunodeficiency","volume":"46","author":"Oksenhendler","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.iac.2020.03.001_bib7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jaci.2012.04.028","article-title":"Vaccines in the assessment of patients for immune deficiency","volume":"130","author":"Ballow","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2020.03.001_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: defining subgroups in common variable immunodeficiency","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.iac.2020.03.001_bib9","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1086\/606059","article-title":"Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T\u00a0cell defect","volume":"49","author":"Malphettes","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.iac.2020.03.001_bib10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/1744666X.2018.1481750","article-title":"Keeping it in the family: the case for considering late onset combined immunodeficiency a subset of common variable immunodeficiency disorders","volume":"14","author":"Ameratunga","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2020.03.001_bib11","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/713688933","article-title":"The simultaneous presentation of sarcoidosis and common variable immune deficiency","volume":"32","author":"Ameratunga","year":"2000","journal-title":"Pathology"},{"issue":"5","key":"10.1016\/j.iac.2020.03.001_bib12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00005792-199609000-00002","article-title":"Sarcoidosis and common variable immunodeficiency.Report of 8 cases and review of the literature","volume":"75","author":"Fasano","year":"1996","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1016\/j.iac.2020.03.001_bib13","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1038\/ajg.2010.214","article-title":"The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease","volume":"105","author":"Malamut","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"431026","key":"10.1016\/j.iac.2020.03.001_bib14","first-page":"2019000929","article-title":"Current genetic landscape in common variable immune deficiency","volume":"15","author":"Abolhassani","year":"2020","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.iac.2020.03.001_bib15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s12016-017-8645-0","article-title":"Review: diagnosing common variable immunodeficiency disorder in the era of genome sequencing","volume":"54","author":"Ameratunga","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.iac.2020.03.001_bib16","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fimmu.2016.00220","article-title":"Genetic diagnosis using whole exome sequencing in common variable immunodeficiency","volume":"7","author":"Maffucci","year":"2016","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.iac.2020.03.001_bib17","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1038\/cti.2017.41","article-title":"Epistatic interactions between mutations of TACI (TNFRSF13B) and TCF3 result in a severe primary immunodeficiency disorder and systemic lupus erythematosus","volume":"6","author":"Ameratunga","year":"2017","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.iac.2020.03.001_bib18","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.3389\/fimmu.2017.01965","article-title":"Clinical implications of digenic inheritiance and epistasis in primary immunodeficiency disorders","volume":"8","author":"Ameratunga","year":"2018","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.iac.2020.03.001_bib19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng0407-429","article-title":"Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency","volume":"39","author":"Pan-Hammarstrom","year":"2007","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.iac.2020.03.001_bib20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10875-012-9793-x","article-title":"Clinical variability of family members with the C104R mutation in transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI)","volume":"33","author":"Koopmans","year":"2013","journal-title":"J\u00a0Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2020.03.001_bib21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/cei.12178","article-title":"New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin","volume":"174","author":"Ameratunga","year":"2013","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.iac.2020.03.001_bib22","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/clim.1999.4799","article-title":"Diagnostic criteria for primary immunodeficiencies.Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies)","volume":"93","author":"Conley","year":"1999","journal-title":"Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2020.03.001_bib23","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/(SICI)1098-2825(1998)12:6<363::AID-JCLA6>3.0.CO;2-X","article-title":"Reference distributions for immunoglobulins A, G, and M: a practical, simple, and clinically relevant approach in a large cohort","volume":"12","author":"Ritchie","year":"1998","journal-title":"J\u00a0Clin Lab Anal"},{"issue":"6","key":"10.1016\/j.iac.2020.03.001_bib24","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2141.2009.07669.x","article-title":"Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions","volume":"145","author":"Chapel","year":"2009","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.iac.2020.03.001_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1586\/1744666X.2014.870478","article-title":"Is there a need to redefine the diagnostic criteria for common variable immunodeficiency?","volume":"10","author":"Seppanen","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.001_bib26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/B978-0-12-385991-4.00002-7","article-title":"\"A rose is a rose is a rose,\" but CVID is Not CVID common variable immune deficiency (CVID), what do we know in 2011?","volume":"111","author":"Yong","year":"2011","journal-title":"Adv Immunol"},{"issue":"3","key":"10.1016\/j.iac.2020.03.001_bib27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1586\/1744666X.2016.1126509","article-title":"Application of diagnostic and treatment criteria for common variable immunodeficiency disorder","volume":"12","author":"Ameratunga","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2020.03.001_bib28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1586\/1744666X.2014.875274","article-title":"New diagnostic criteria for CVID","volume":"10","author":"Ameratunga","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"issue":"37","key":"10.1016\/j.iac.2020.03.001_bib29","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.1016\/j.vaccine.2012.06.073","volume":"30","author":"Thierry-Carstensen","year":"2012","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.iac.2020.03.001_bib30","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1128\/CVI.00101-12","article-title":"Immune response to Haemophilus influenzae type b vaccination in patients with chronic renal failure","volume":"19","author":"Hawdon","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.iac.2020.03.001_bib31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4161\/hv.2.1.2445","article-title":"Immunogenicity and reactogenicity to Haemophilus influenzae type B (Hib) conjugate vaccine among rural Alaska adults","volume":"2","author":"Dentinger","year":"2006","journal-title":"Hum Vaccin"},{"issue":"10","key":"10.1016\/j.iac.2020.03.001_bib32","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.3389\/fimmu.2019.01541","article-title":"The natural history of untreated primary hypogammaglobulinemia in adults: implications for the diagnosis and treatment of Common Variable Immunodeficiency Disorders (CVID)","volume":"17","author":"Ameratunga","year":"2019","journal-title":"Front Immunol"},{"issue":"Pt 6","key":"10.1016\/j.iac.2020.03.001_bib33","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/0004563213500241","article-title":"Making sense of serotype-specific pneumococcal antibody measurements","volume":"50","author":"Beck","year":"2013","journal-title":"Ann Clin Biochem"},{"issue":"5 Suppl 1","key":"10.1016\/j.iac.2020.03.001_bib34","first-page":"S1","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"94","author":"Bonilla","year":"2005","journal-title":"Ann AllergyAsthma Immunol"},{"issue":"5","key":"10.1016\/j.iac.2020.03.001_bib35","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S1081-1206(10)60572-8","article-title":"Assessment and clinical interpretation of polysaccharide antibody responses","volume":"99","author":"Paris","year":"2007","journal-title":"Ann AllergyAsthma Immunol"},{"issue":"30","key":"10.1016\/j.iac.2020.03.001_bib36","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1016\/j.vaccine.2012.04.052","article-title":"Pneumococcal polysaccharide 23-valent vaccine: long-term persistence of circulating antibody and immunogenicity and safety after revaccination in adults","volume":"30","author":"Grabenstein","year":"2012","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.iac.2020.03.001_bib37","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/sji.12028","article-title":"Variability of memory B cell markers in a cohort of Common Variable Immune Deficiency patients over six months","volume":"77","author":"Koopmans","year":"2013","journal-title":"Scand J Immunol"},{"issue":"3","key":"10.1016\/j.iac.2020.03.001_bib38","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2249.2009.04062.x","article-title":"Immunological and clinical profile of adult patients with selective immunoglobulin subclass deficiency: response to intravenous immunoglobulin therapy","volume":"159","author":"Abrahamian","year":"2010","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.iac.2020.03.001_bib39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/00365540600951192","article-title":"Immunoglobulin prophylaxis in 350 adults with IgG subclass deficiency and recurrent respiratory tract infections: a long-term follow-up","volume":"39","author":"Olinder-Nielsen","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.iac.2020.03.001_bib40","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1710-1492-9-36","article-title":"Hypogammaglobulinemia factitia. Munchausen syndrome presenting as Common Variable Immune Deficiency","volume":"9","author":"Ameratunga","year":"2013","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"1195","key":"10.1016\/j.iac.2020.03.001_bib41","first-page":"U914","article-title":"The assessment and management of primary antibody deficiency","volume":"117","author":"Empson","year":"2004","journal-title":"N\u00a0Z Med J"},{"issue":"6","key":"10.1016\/j.iac.2020.03.001_bib42","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10875-015-0189-6","article-title":"Profound reversible hypogammaglobulinemia caused by celiac disease in the absence of protein losing enteropathy","volume":"35","author":"Ameratunga","year":"2015","journal-title":"J\u00a0Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2020.03.001_bib43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/cen3.12135","article-title":"New diagnostic criteria could distinguish common variable immunodeficiency disorder from anticonvulsant-induced hypogammaglobulinemia","volume":"6","author":"Ameratunga","year":"2015","journal-title":"Clin Exp Neuroimmunol"},{"key":"10.1016\/j.iac.2020.03.001_bib44","first-page":"78","article-title":"The critical role of histology in distinguishing sarcoidosis from common variable immunodeficiency disorder (CVID) in a patient with hypogammaglobulinemia","volume":"15","author":"Ameratunga","year":"2019","journal-title":"AllergyAsthma Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2020.03.001_bib45","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1212\/01.WNL.0000113754.29225.5D","article-title":"Lamotrigine-induced common variable immune deficiency","volume":"62","author":"Smith","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.iac.2020.03.001_bib46","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International Consensus Document (ICON): common variable immunodeficiency disorders","volume":"4","author":"Bonilla","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.iac.2020.03.001_bib47","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/cei.13345","article-title":"Transient hypogammaglobulinemia of infancy: many patients recover in adolescence and adulthood","volume":"198","author":"Ameratunga","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.iac.2020.03.001_bib48","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3389\/fimmu.2017.01190","article-title":"Unexpectedly high prevalence of common variable immunodeficiency in Finland","volume":"8","author":"Selenius","year":"2017","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.iac.2020.03.001_bib49","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/sji.12551","article-title":"Identification and characterization of a nationwide danish adult common variable immunodeficiency cohort","volume":"85","author":"Westh","year":"2017","journal-title":"Scand J Immunol"},{"issue":"3 Suppl","key":"10.1016\/j.iac.2020.03.001_bib50","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2012.07.002","article-title":"Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology","volume":"130","author":"Orange","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.iac.2020.03.001_bib51","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3324\/haematol.2013.085076","article-title":"Common variable immunodeficiency and idiopathic primary hypogammaglobulinemia: two different conditions within the same disease spectrum","volume":"98","author":"Driessen","year":"2013","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.iac.2020.03.001_bib52","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jaip.2018.12.004","article-title":"Differentiation of common variable immunodeficiency from IgG deficiency","volume":"7","author":"Filion","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2020.03.001_bib53","article-title":"Perspective: evolving concepts in the diagnosis and understanding of Common Variable Immunodeficiency Disorders (CVID)","author":"Ameratunga","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"issue":"12","key":"10.1016\/j.iac.2020.03.001_bib54","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1097\/PAS.0b013e3180cab60c","article-title":"Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review","volume":"31","author":"Daniels","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.iac.2020.03.001_bib55","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1086\/649839","article-title":"Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults","volume":"201","author":"Musher","year":"2010","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.iac.2020.03.001_bib56","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s10875-013-9873-6","article-title":"Nodular regenerative hyperplasia in common variable immunodeficiency","volume":"33","author":"Fuss","year":"2013","journal-title":"J\u00a0Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2020.03.001_bib57","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jhep.2007.08.011","article-title":"Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities","volume":"48","author":"Malamut","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.iac.2020.03.001_bib58","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2807\/ese.17.46.20313-en","article-title":"Haemophilus influenzae serotype B (Hib) seroprevalence in England and Wales in 2009","volume":"17","author":"Ladhani","year":"2012","journal-title":"Euro Surveill"},{"issue":"3","key":"10.1016\/j.iac.2020.03.001_bib59","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.clim.2007.04.011","article-title":"Active vaccination in patients with common variable immunodeficiency (CVID)","volume":"124","author":"Goldacker","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1016\/j.iac.2020.03.001_bib60","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2334-10-60","article-title":"The effect of age on the response to the pneumococcal polysaccharide vaccine","volume":"10","author":"Lee","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"9","key":"10.1016\/j.iac.2020.03.001_bib61","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(07)70210-4","article-title":"Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue?","volume":"7","author":"O'Brien","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.iac.2020.03.001_bib62","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10875-012-9806-9","article-title":"Serotype-specific anti-pneumococcal IgG and immune competence: critical differences in interpretation criteria when different methods are used","volume":"33","author":"Balloch","year":"2013","journal-title":"J\u00a0Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2020.03.001_bib63","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1086\/422531","article-title":"Concentration of antipneumococcal antibodies as a serological correlate of protection: an application to acute otitis media","volume":"190","author":"Jokinen","year":"2004","journal-title":"J\u00a0Infect Dis"},{"issue":"3","key":"10.1016\/j.iac.2020.03.001_bib64","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.vaccine.2010.10.046","article-title":"Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12\u00a0months of age","volume":"29","author":"Russell","year":"2011","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.iac.2020.03.001_bib65","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1016\/S0264-410X(03)00230-5","article-title":"Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants","volume":"21","author":"Jodar","year":"2003","journal-title":"Vaccine"},{"issue":"17\u201318","key":"10.1016\/j.iac.2020.03.001_bib66","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/S0264-410X(03)00025-2","article-title":"Correlates of immunity for pneumococcal conjugate vaccines","volume":"21","author":"Lee","year":"2003","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.iac.2020.03.001_bib67","first-page":"12","article-title":"The clinical utility of molecular diagnostic testing for primary immune deficiency disorders: a case based review","volume":"6","author":"Ameratunga","year":"2010","journal-title":"AllergyAsthma Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2020.03.001_bib68","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1128\/CVI.00389-09","article-title":"Serum bactericidal antibody response 1 year after meningococcal polysaccharide vaccination of patients with common variable immunodeficiency","volume":"17","author":"Rezaei","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"12","key":"10.1016\/j.iac.2020.03.001_bib69","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1172\/JCI106756","article-title":"Immunologic responses to bacteriophage phi-X 174 in immunodeficiency diseases","volume":"50","author":"Ochs","year":"1971","journal-title":"J\u00a0Clin Invest"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856120300138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856120300138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:42:40Z","timestamp":1760179360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856120300138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0889856120300138"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2020.03.001","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining Common Variable Immunodeficiency Disorders in 2020","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2020.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}